<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34508537</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>09</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>09</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1815-672X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>59</Volume>
            <Issue>236</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Apr</Month>
              <Day>30</Day>
            </PubDate>
          </JournalIssue>
          <Title>JNMA; journal of the Nepal Medical Association</Title>
          <ISOAbbreviation>JNMA J Nepal Med Assoc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Kawasaki Disease- Management Strategies Given Symptoms Overlap to COVID-19: A Review.</ArticleTitle>
        <Pagination>
          <StartPage>417</StartPage>
          <EndPage>424</EndPage>
          <MedlinePgn>417-424</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.31729/jnma.5698</ELocationID>
        <Abstract>
          <AbstractText>Kawasaki disease is an acute, self-limiting vasculitis in children. Early treatment is necessary to prevent cardiovascular complications. The acute phase of Kawasaki disease may present with hemodynamic instability. An association between viral respiratory infections and Kawasaki disease has been reported. Studies have shown that Kawasaki and Kawasaki-like disease may be associated with and have symptoms overlapping COVID-19. Children with COVID-19 may present as Kawasaki-like disease with pediatric inflammatory multisystem syndrome, or macrophage activation syndrome. Clinicians need to be aware of the early diagnosis and management of Kawasaki disease to prevent the development of coronary artery aneurysms. The symptoms overlap of multisystem inflammatory disease seen in COVID-19 adds to the difficulties in timely diagnosis and treatment. Children with Kawasaki disease require regular follow-up plans for coronary artery aneurysms. This adds to the difficulties during the changed environment of COVID-19 for control and prevention. Missed diagnosis and early treatment of Kawasaki disease with immunoglobulin and aspirin results in the development of coronary artery aneurysm in up to 25% of cases, with grave consequences. Here, we briefly review the management of typical and atypical Kawasaki disease which has symptoms overlapping with the multisystem inflammatory disease as seen in COVID-19.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Linna</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Xi'an Medical University, Xi'an, 710068, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Sheng</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Ji</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ni</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Juyan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xiaohong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mu</LastName>
            <ForeName>Zhilong</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Gaitao</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shah</LastName>
            <ForeName>Jenifei</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shah</LastName>
            <ForeName>Jay</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Patan Hospital, Patan Academy of Health Sciences, Kathmandu, Nepal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiao</LastName>
            <ForeName>Fuyong</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Shaanxi Provincial People's Hospital, 3rd Affiliated Hospital of Medical College of Xi'an Jiao Tong University, Xi'an Shanxi, 710001, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>04</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>JNMA J Nepal Med Assoc</MedlineTA>
        <NlmUniqueID>0045233</NlmUniqueID>
        <ISSNLinking>0028-2715</ISSNLinking>
      </MedlineJournalInfo>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009080" MajorTopicYN="Y">Mucocutaneous Lymph Node Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>
<b>None.</b>
</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>11</Day>
          <Hour>12</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34508537</ArticleId>
        <ArticleId IdType="pmc">PMC8369595</ArticleId>
        <ArticleId IdType="doi">10.31729/jnma.5698</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974 Sep;54(3):271–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4153258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.  Circulation. 1996 Sep 15;94(6):1379–85. doi: 10.1161/01.CIR.94.6.1379.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.94.6.1379</ArticleId>
            <ArticleId IdType="pubmed">8822996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Q, Liu J, Mu Z, Yan X, Shah JN, Jiao F. Clinical profile of covid-19 in children and research progress on angiotensinconverting enzyme 2: A Mini-review. JNMA J Nepal Med Assoc. 2020 Oct 15;58(230):813–9. doi: 10.31729/jnma.5436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.31729/jnma.5436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al.  Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. doi: 10.1542/peds.2020-0702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2020-0702</ArticleId>
            <ArticleId IdType="pubmed">32179660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akca UK, Kesici S, Ozsurekci Y, Aykan HH, Batu ED, Atalay E, et al.  Kawasaki-like disease in children with COVID-19. Rheumatol Int. 2020 Dec;40(12):2105–151. doi: 10.1007/s00296-020-04701-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-020-04701-6</ArticleId>
            <ArticleId IdType="pmc">PMC7492688</ArticleId>
            <ArticleId IdType="pubmed">32936318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Belhadjer Z, Meot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al.  Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020 Aug 4;142(5):429–36. doi: 10.1161/CIRCULATIONAHA.120.048360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.048360</ArticleId>
            <ArticleId IdType="pubmed">32418446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al.  Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020 Mar;369:m2094. doi: 10.1136/bmj.m2094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.m2094</ArticleId>
            <ArticleId IdType="pmc">PMC7500538</ArticleId>
            <ArticleId IdType="pubmed">32493739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harwood R, Allin B, Jones CE, Whittaker E, Ramnarayan P, Ramanan AV, et al.  A national consensus management pathway for pediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolesc Health. 2020 Sep 18; S2352-4642(20)30304-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7500943</ArticleId>
            <ArticleId IdType="pubmed">32956615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al.  An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020 Jun 6;395(10239):1771–8. doi: 10.1016/S0140-6736(20)31103-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(20)31103-X</ArticleId>
            <ArticleId IdType="pmc">PMC7220177</ArticleId>
            <ArticleId IdType="pubmed">32410760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panupattanapong S, Brooks EB. New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response. Cleve Clin J Med. 2020 Jun 3; doi: 10.3949/ccjm.87a.ccc039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3949/ccjm.87a.ccc039</ArticleId>
            <ArticleId IdType="pubmed">32493734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W, Gong F, Zhu W, Fu S, Zhang Q. Macrophage activation syndrome in Kawasaki disease: more common than we thought? Semin Arthritis Rheum. 2015 Feb;44(4):405–10. doi: 10.1016/j.semarthrit.2014.07.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2014.07.007</ArticleId>
            <ArticleId IdType="pubmed">25200945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanegaye JT, Wilder MS, Molkara D, Frazer JR, Pancheri J, Tremoulet AH, et al.  Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009 May;123(5):e783–9. doi: 10.1542/peds.2008-1871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2008-1871</ArticleId>
            <ArticleId IdType="pmc">PMC2848476</ArticleId>
            <ArticleId IdType="pubmed">19403470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, et al.  A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Mil Med Res. 2020 Feb 6;7(1):4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7003341</ArticleId>
            <ArticleId IdType="pubmed">32029004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turnier JL, Anderson MS, Heizer HR, Jone P-N, Glodé MP, Dominguez SR. Concurrent Respiratory Viruses and Kawasaki Disease. Pediatrics. 2015 Sep 1;136(3):e609–14. doi: 10.1542/peds.2015-0950.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2015-0950</ArticleId>
            <ArticleId IdType="pubmed">26304824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang L-Y, Lu C-Y, Shao P-L, Lee P-I, Lin M-T, Fan T-Y, et al.  Viral infections associated with Kawasaki disease. J Formos Med Assoc. 2014 Mar 1;113(3):148–54. doi: 10.1016/j.jfma.2013.12.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jfma.2013.12.008</ArticleId>
            <ArticleId IdType="pmc">PMC7125523</ArticleId>
            <ArticleId IdType="pubmed">24495555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, et al.  Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. 2020;79(8):999–1006. doi: 10.1136/annrheumdis-2020-217960.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2020-217960</ArticleId>
            <ArticleId IdType="pmc">PMC7299653</ArticleId>
            <ArticleId IdType="pubmed">32527868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020 Jun;395(10239):1771–8. doi: 10.1016/S0140-6736(20)31103-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(20)31103-X</ArticleId>
            <ArticleId IdType="pmc">PMC7220177</ArticleId>
            <ArticleId IdType="pubmed">32410760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, et al.  Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;4(9):669–77. doi: 10.1016/S2352-4642(20)30215-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2352-4642(20)30215-7</ArticleId>
            <ArticleId IdType="pmc">PMC7347350</ArticleId>
            <ArticleId IdType="pubmed">32653054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al.  Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020 Jul 21;324(3):259–69. doi: 10.1001/jama.2020.10369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId>
            <ArticleId IdType="pmc">PMC7281356</ArticleId>
            <ArticleId IdType="pubmed">32511692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rowley AH, Shulman ST. Kawasaki Syndrome. Clin Microbiol Rev. 1998 Jul;11(3):405–14. doi: 10.1128/CMR.11.3.405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.11.3.405</ArticleId>
            <ArticleId IdType="pmc">PMC88887</ArticleId>
            <ArticleId IdType="pubmed">9665974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004 Aug 7;364(9433):533–44. doi: 10.1016/S0140-6736(04)16814-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(04)16814-1</ArticleId>
            <ArticleId IdType="pubmed">15302199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newburger JW, Takahashi M, Burns JC. Kawasaki Disease. J Am Coll Cardiol. 2016 Apr 12;67(14):1738–49. doi: 10.1016/j.jacc.2015.12.073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2015.12.073</ArticleId>
            <ArticleId IdType="pubmed">27056781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh S, Sharma A, Jiao F. Kawasaki Disease: Issues in Diagnosis and Treatment--A Developing Country Perspective. Indian J Pediatr. 2016 Feb;83(2):140–5. doi: 10.1007/s12098-015-1890-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12098-015-1890-4</ArticleId>
            <ArticleId IdType="pubmed">26400032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medeiros R, de Magalhaes C, Coutinho de Almeida F, Gandolfi L, Pratesi R, Ribeiro de M., Alves N, Selleski N, et al.  Clinical manifestations of kawasaki disease at different age spectrum: a ten-year study. Medicina (Kaunas) 2020 Mar 25;56(4):145. doi: 10.3390/medicina56040145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/medicina56040145</ArticleId>
            <ArticleId IdType="pmc">PMC7231131</ArticleId>
            <ArticleId IdType="pubmed">32218369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin M-T, Wu M-H. The global epidemiology of Kawasaki disease: Review and future perspectives. Glob Cardiol Sci Pract. 2017 Oct 31;2017(3):e201720. doi: 10.21542/gcsp.2017.20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21542/gcsp.2017.20</ArticleId>
            <ArticleId IdType="pmc">PMC5856963</ArticleId>
            <ArticleId IdType="pubmed">29564341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JCS Joint Working Group.  Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013) Digest version. Circ J. 2014;78(10):2521–62. doi: 10.1253/circj.CJ-66-0096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1253/circj.CJ-66-0096</ArticleId>
            <ArticleId IdType="pubmed">25241888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elakabawi K, Lin J, Jiao F, Guo N, Yuan Z. Kawasaki Disease: Global Burden and Genetic Background. Cardiol Res. 2020 Feb;11(1):9–14. doi: 10.14740/cr993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14740/cr993</ArticleId>
            <ArticleId IdType="pmc">PMC7011927</ArticleId>
            <ArticleId IdType="pubmed">32095191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marrani E, Burns JC, Cimaz R. How Should We Classify Kawasaki Disease? Front Immunol. 2018;9:2974. doi: 10.3389/fimmu.2018.02974.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2018.02974</ArticleId>
            <ArticleId IdType="pmc">PMC6302019</ArticleId>
            <ArticleId IdType="pubmed">30619331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The Royal Children's Hospital Melbourne.   Clinical Practice Guidelines: Kawasaki disease [Internet] Victoria, Australia: The Royal Children Hospital Melbourne;  [2021 Jan]. https://www.rch.org.au/clinicalguide/guideline_index/Kawasaki_disease/ Available from:</Citation>
        </Reference>
        <Reference>
          <Citation>Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, et al.  Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol. 2012;22(3):216–21. doi: 10.2188/jea.JE20110126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2188/jea.JE20110126</ArticleId>
            <ArticleId IdType="pmc">PMC3798622</ArticleId>
            <ArticleId IdType="pubmed">22447211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al.  Diagnosis, treatment, and long-term management of kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, american heart association. Pediatrics. 2004 Dec;114(6):1708–33. doi: 10.1542/peds.2004-2182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2004-2182</ArticleId>
            <ArticleId IdType="pubmed">15574639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCrindle Brian W, Rowley Anne H, Newburger Jane W, Burns Jane C, Bolger Anne F, Michael Gewitz, et al.  Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation. 2017 Apr 25;135(17):e927–99. doi: 10.1161/CIR.0000000000000484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId>
            <ArticleId IdType="pubmed">28356445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan F, Pan B, Sun H, Tian J, Li M. Risk factors of coronary artery abnormality in children with kawasaki disease: a systematic review and meta-analysis. Front Pediatr. 2019 Sep 26;7:374. doi: 10.3389/fped.2019.00374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fped.2019.00374</ArticleId>
            <ArticleId IdType="pmc">PMC6776089</ArticleId>
            <ArticleId IdType="pubmed">31612117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu JJ. Diagnosis of incomplete Kawasaki disease. Korean J Pediatr. 2012 Mar;55(3):83–7. doi: 10.3345/kjp.2012.55.3.83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3345/kjp.2012.55.3.83</ArticleId>
            <ArticleId IdType="pmc">PMC3315623</ArticleId>
            <ArticleId IdType="pubmed">22474462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al.  Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation. 2017 Apr;135(25)(17):e927–99. doi: 10.1161/CIR.0000000000000484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId>
            <ArticleId IdType="pubmed">28356445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Research Committee of the Japanese Society of Pediatric Cardiology, Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease.  Guidelines for medical treatment of acute kawasaki disease: report of the research committee of the japanese society of pediatric cardiology and cardiac surgery (2012 revised version) Pediatr Int. 2014 Apr;56(2):135–58. doi: 10.1111/ped.12317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ped.12317</ArticleId>
            <ArticleId IdType="pubmed">24730626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi J-W. Can we get a clue for the etiology of Kawasaki disease in the COVID-19 pandemic? Clin Exp Pediatr. 2020 Jul 13;63(9):335–6. doi: 10.3345/cep.2020.00955.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3345/cep.2020.00955</ArticleId>
            <ArticleId IdType="pmc">PMC7462826</ArticleId>
            <ArticleId IdType="pubmed">32683814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rowley AH, Shulman ST. The epidemiology and pathogenesis of kawasaki disease. Front Pediatr. 2018;6:374. doi: 10.3389/fped.2018.00374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fped.2018.00374</ArticleId>
            <ArticleId IdType="pmc">PMC6298241</ArticleId>
            <ArticleId IdType="pubmed">30619784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jy Z, Jy Y, Jm Q. Interpretations of "diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7)". Chin Med J (Engl) 2020 Jun 1;133(11):1347–9. doi: 10.1097/CM9.0000000000000866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CM9.0000000000000866</ArticleId>
            <ArticleId IdType="pmc">PMC7289291</ArticleId>
            <ArticleId IdType="pubmed">32301757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang RL, Lo HH, Lei C, Ip N, Chen J, Law BY-K. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. Curr Opin Pharmacol. 2020 Sep 18;54:72–81. doi: 10.1016/j.coph.2020.08.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.coph.2020.08.008</ArticleId>
            <ArticleId IdType="pmc">PMC7500898</ArticleId>
            <ArticleId IdType="pubmed">32956895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding H, Shi Z, Ruan Z, Cheng X, Li R, Zhang L, et al.  Consideration of the management of pediatric fever clinics during the novel coronavirus pneumonia outbreak. Disaster Med Public Health Prep. 2020 Aug 12;:1–7. doi: 10.1017/dmp.2020.289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/dmp.2020.289</ArticleId>
            <ArticleId IdType="pmc">PMC7642910</ArticleId>
            <ArticleId IdType="pubmed">32782044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Ma B, Lin L-X, Xue Y-M. Treatment of Kawasaki disease by different doses of immunoglobulin: a meta analysis of efficacy and safety. Transl Pediatr. 2012 Oct;1(2):99–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4728885</ArticleId>
            <ArticleId IdType="pubmed">26835271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuo H-C, Lo M-H, Hsieh K-S, Guo MM-H, Huang Y-H. High-Dose Aspirin is associated with anemia and does not confer benefit to disease outcomes in kawasaki disease. PloS One. 2015;10(12):e0144603. doi: 10.1371/journal.pone.0144603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0144603</ArticleId>
            <ArticleId IdType="pmc">PMC4686074</ArticleId>
            <ArticleId IdType="pubmed">26658843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwon JE, Roh DE, Kim YH. The impact of moderate-dose acetylsalicylic acid in the reduction of inflammatory cytokine and prevention of complication in acute phase of kawasaki disease: the benefit of moderate-dose acetylsalicylic acid. Child Basel Switz. 2020 Oct 16;7(10) doi: 10.3390/children7100185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/children7100185</ArticleId>
            <ArticleId IdType="pmc">PMC7602855</ArticleId>
            <ArticleId IdType="pubmed">33081227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito Y, Matsui T, Abe K, Honda T, Yasukawa K, Takanashi J-I, et al.  Aspirin dose and treatment outcomes in kawasaki disease: a historical control study in japan. Front Pediatr. 2020;8:249. doi: 10.3389/fped.2020.00249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fped.2020.00249</ArticleId>
            <ArticleId IdType="pmc">PMC7241278</ArticleId>
            <ArticleId IdType="pubmed">32478021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duignan S, Doyle SL, McMahon CJ. Refractory Kawasaki disease: diagnostic and management challenges. Pediatric Health Med Ther. 2019 Oct 30;10:131–139. doi: 10.2147/PHMT.S165935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/PHMT.S165935</ArticleId>
            <ArticleId IdType="pmc">PMC6826175</ArticleId>
            <ArticleId IdType="pubmed">31802968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Chen Y, Tang Y, Ding Y, Xu Q, Sun L, et al.  Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases. Eur J Pediatr. 2018 Aug;177(8):1279–92. doi: 10.1007/s00431-018-3182-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00431-018-3182-2</ArticleId>
            <ArticleId IdType="pmc">PMC6061038</ArticleId>
            <ArticleId IdType="pubmed">29948255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noguchi S, Saito J, Kudo T, Hashiba E, Hirota K. Safety and efficacy of plasma exchange therapy for Kawasaki disease in children in intensive care unit: case series. J A Clin Rep. 2018;4(1):25. doi: 10.1186/s40981-018-0156-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40981-018-0156-3</ArticleId>
            <ArticleId IdType="pmc">PMC5840196</ArticleId>
            <ArticleId IdType="pubmed">29541684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hokosaki T, Mori M, Nishizawa T, Nakamura T, Imagawa T, Iwamoto M, et al.  Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease. Pediatr Int Off J Jpn Pediatr Soc. 2012 Feb;54(1):99–103. doi: 10.1111/j.1442-200X.2011.03487.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1442-200X.2011.03487.x</ArticleId>
            <ArticleId IdType="pubmed">22004042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyer K, Volkmann A, Hufnagel M, Schachinger E, Klau S, Horstmann J, et al.  Breastfeeding and vitamin d supplementation reduce the risk of kawasaki disease in a german population-based case-control study. BMC Pediatr. 2019 Feb 26;19(1):66. doi: 10.1186/s12887-019-1438-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12887-019-1438-2</ArticleId>
            <ArticleId IdType="pmc">PMC6390341</ArticleId>
            <ArticleId IdType="pubmed">30808315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jun JS, Jung YK, Lee DW. Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease. Korean J Pediatr. 2017 Jul 31;60(7):216–20. doi: 10.3345/kjp.2017.60.7.216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3345/kjp.2017.60.7.216</ArticleId>
            <ArticleId IdType="pmc">PMC5573744</ArticleId>
            <ArticleId IdType="pubmed">28861112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon JB, Kahn AM, Burns JC. When children with kawasaki disease grow up: myocardial and vascular complications in adulthood. J Am Coll Cardiol. 2009 Nov 17;54(21):1911–20. doi: 10.1016/j.jacc.2009.04.102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2009.04.102</ArticleId>
            <ArticleId IdType="pmc">PMC2870533</ArticleId>
            <ArticleId IdType="pubmed">19909870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, et al.  Guidelines for long-term management of patients with kawasaki disease. report from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, american heart association. Circulation. 1994 Feb;89(2):916–22. doi: 10.1161/01.CIR.89.2.916.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.89.2.916</ArticleId>
            <ArticleId IdType="pubmed">8313588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balasubramanian S, Krishna MR, Dhanalakshmi K, Amperayani S, Ramanan AV. Factors associated with delay in diagnosis of Kawasaki disease in India. Indian Pediatr. 2012 Aug;49(8):663–5. doi: 10.1007/s13312-012-0130-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13312-012-0130-5</ArticleId>
            <ArticleId IdType="pubmed">22962240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiao F, Jindal AK, Pandiarajan V, Khubchandani R, Kamath N, Sabui T, et al.  The emergence of kawasaki disease in india and china. Glob Cardiol Sci Pract. 2017 Oct 31;2017(3):e201721. doi: 10.21542/gcsp.2017.21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21542/gcsp.2017.21</ArticleId>
            <ArticleId IdType="pmc">PMC5856971</ArticleId>
            <ArticleId IdType="pubmed">29564342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh S, Kawasaki T. Kawasaki disease in india, lessons learnt over the last 20 years. Indian Pediatr. 2016 Feb;53(2):119–24. doi: 10.1007/s13312-016-0804-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13312-016-0804-5</ArticleId>
            <ArticleId IdType="pubmed">26897142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajak K, Twayana AR, Shrestha R, Amatya P, Ghimire C. Prevalence of kawasaki disease in a tertiary care hospital: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2019 Dec;57(220):408–11. doi: 10.31729/jnma.4746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.31729/jnma.4746</ArticleId>
            <ArticleId IdType="pmc">PMC7580414</ArticleId>
            <ArticleId IdType="pubmed">32335650</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
